Marlène O.
- Country
- France
- Department
- Service Hematologie
Research Overview
- Efficacy of Venetoclax Plus Cytarabine Versus Idarubicin Plus Cytarabine in Post-Remission Therapy for Elderly Patients with Acute Myeloid Leukemia
- TRANSCRIPT: An open label, controlled, randomized multicentric international study evaluating the benefit of autologous stem cell transplantation after complete response in frontline setting patients with T cell-lymphoma
- Phase 2 Study on Zanubrutinib and BGB-11417 Efficacy and Tolerance in Previously Treated Waldenström Macroglobulinemia Patients
Data & Insights
Has run more than one trial at 81 of 198 partner sites.
Specializations
Lymphoma Research
The investigator specializes in treating various forms of lymphoid malignancies, with particular focus on T-cell lymphomas and B-cell lymphomas. Their expertise extends to both aggressive and indolent forms of these diseases.
- Peripheral T-cell Lymphoma (PTCL)
- Marginal Zone Lymphoma
- B-cell Lymphoma variants
- Waldenström Macroglobulinemia
Leukemia Treatment
The investigator has extensive experience in treating hematologic malignancies, particularly focusing on various forms of leukemia and their management strategies.
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
- Acute Myeloid Leukemia
Multiple Myeloma Management
The investigator's work includes specialized treatment approaches for multiple myeloma, with particular attention to transplant-ineligible patients and novel therapeutic combinations.
- Newly diagnosed multiple myeloma
- Transplant-ineligible patient care
- Novel therapeutic combinations
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.